Navigation Links
Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
Date:7/29/2009

EMERYVILLE, Calif., July 29 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a drug discovery and development company focused on the unmet needs in women's health and oncology, today announced that Dr. Mary Tagliaferri, President and Chief Medical Officer, and Tom Chesterman, Senior Vice President and CFO, will be presenting at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference at 1:45 p.m. EDT on Wednesday, August 5, 2009. The event will be held at the Millennium Broadway Hotel in New York City.

Interested parties can access a live webcast of the presentation by visiting http://www.bmocm.com/conferences/2009healthcare/webcast/. A replay will be available for 6 months following the conference.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.biono
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bionovo Announces Closing of Public Offering of Common Stock
2. Bionovo Describes a New Class of Therapeutic Compounds
3. Bionovo Announces 2007 Financial Results and Highlights
4. Bionovo to Present at the Cambria Capital Investor Meeting
5. John D. Baxter, M.D. Joins Bionovos Board of Directors
6. Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
7. Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
8. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Announces Cost Control Measures Taken
10. Bionovo Announces Presentation at the National Cancer Institute
11. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... success of musical artists to crowd-funding campaigns that give small businesses financial support, ... health solutions company and innovator in employee health management programs, unveiled today a ...
(Date:7/29/2015)... ... July 29, 2015 , ... Gender minority people ... 2012, Massachusetts law has provided legal protections against discrimination on the basis of ... not protect against discrimination based on gender identity in places open to the ...
(Date:7/29/2015)... Washington, DC (PRWEB) , ... July 29, 2015 , ... ... a company rebrand, changing its name to Rock the Reformer ® by Potomac Pilates. ... website - http://www.RockTheReformer.com . Rock the Reformer ® by Potomac Pilates will continue ...
(Date:7/29/2015)... ... July 29, 2015 , ... More than 28,000 students ... of children living with autism will converge upon Penn State to share the ... The National Autism Conference will be held Aug. 3-6 at the Penn Stater ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA re-accredited the ... expiring November 30, 2019, during its recent meeting. , The Commission received renewal ... program’s compliance with the NCCA’s Standards for the Accreditation of Certification Programs. ...
Breaking Medicine News(10 mins):Health News:StayWell Unveils Employer Guide to Developing Effective Employee Wellness Champion Networks 2Health News:StayWell Unveils Employer Guide to Developing Effective Employee Wellness Champion Networks 3Health News:StayWell Unveils Employer Guide to Developing Effective Employee Wellness Champion Networks 4Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3
... , , BASKING RIDGE, N.J., Sept. ... the development of antithrombotic therapeutic aptamers with active control ... the first patient in a Phase 2b, randomized, partially-blinded, ... the REG1 anticoagulation system (REG1) was achieved. REG1 ...
... TARRYTOWN, N.Y., Sept. 9 Bayer Diabetes Care today ... glucose meters -- Pink and Purple. , , ... to use(1) features as the original silver BREEZE2 meter, such as ... so users do not have to handle individual strips every time ...
... to develop PAD if they had constellation of other ... News) -- Women with metabolic syndrome are at high ... dramatically raises the risk of heart disease and stroke. ... taking part in the Women,s Health Study, researchers identified ...
... ... Staffing and Scheduling Earned the Highest Score Based on Direct Product Evaluations and In-depth, ... ... 9, 2009 -- Today at the Nursing Management Congress2009, RES-Q® Healthcare Systems announced that ...
... , WALTHAM, Mass., Sept. 9 ... research and advisory firms focusing on pharmaceutical and healthcare issues, ... messages among the ten surveyed osteoporosis brands likely as a ... commonly recalled that Sally Field promoted the brand or that ...
... , , ATLANTA, ... may have ended, but financial incentives for improving health and appearance ... Surgical Associates, "Cash for Crow,s Feet" program offers a ... at half the typical cost, said Dr. David R. Fern, FACS. ...
Cached Medicine News:Health News:Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System 2Health News:Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System 3Health News:Bayer's BREEZE(R)2 Meter Available in Two New Vibrant Colors for a Limited Time 2Health News:Metabolic Syndrome May Raise Risk of Peripheral Artery Disease 2Health News:RES-Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 2Health News:Both Patients and Physicians Most Frequently Recall Roche's Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 2Health News:Both Patients and Physicians Most Frequently Recall Roche's Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 3Health News:'Cash For Crow's Feet' Program Offers Effective - and Affordable - Laser Skin Treatments 2
(Date:7/29/2015)... SAN DIEGO and WALTHAM, Mass., July 29, ... LLP is investigating whether certain officers ... breached their fiduciary duties to shareholders.  AMAG Pharmaceuticals ... on maternal health, anemia, and cancer supportive care.  ... to reduce the risk of preterm birth in ...
(Date:7/29/2015)... July 29, 2015  Cryoport, Inc. (NASDAQ: ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, announced today that the ... stock and warrants (the "Units") under a registered public ...
(Date:7/29/2015)... FRANCISCO , July 29, 2015   KaloBios ... antibody company focused on developing innovative therapies to benefit ... focus on oncology, announced today that the U.S. Food ... new drug (IND) application for KB003, an anti-GM-CSF monoclonal ... and that the IND is now active. ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5
... , PRINCETON, N.J., Nov. 9 Pharmasset, Inc. (Nasdaq: ... Lazard Capital Markets Healthcare Conference. The conference will be held ... 17-19, 2009). , Schaefer Price, Pharmasset,s President and Chief Executive ... November 18, 2009 at 3:45 PM (ET). , To access ...
... 9 Par Pharmaceutical Companies, Inc. (NYSE: PRX ... date and increased the purchase price of its previously ... is offering to purchase, for cash, up to $65,000,000 ... its outstanding 2.875% Senior Subordinated Convertible Notes due 2010. ...
Cached Medicine Technology:Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3
BD Beaver Cataract blade, 30.0 mm long x 2.2 mm wide, designed for ICCE and ECCE procedures, designed for ICCE and ECCE, sterile....
BD Beaver DeBakey blade, 5 mm cutting width, sterile....
... standard trial frames. They are made of optical quality ... box. There are two sets available providing a full ... is that a patient can wear the prism with ... the patient to adapt to the use of the ...
Developed for reconstructive plastic surgery with E-Type coupling. Order blades by size from 12 mm, 25 mm, 50 mm or 75 mm depending on your specific case requirements. Blades come in packs of 10....
Medicine Products: